-
摘要: 乳腺癌是女性最常见的恶性肿瘤之一，多方面因素导致面临生育问题的年轻患者明显增多，而临床工作中多数忽略了她们的生育要求。年轻乳腺癌患者在治疗过程中会出现生育能力下降甚至丧失，选择生育的患者也怀有各种疑虑。本文就乳腺癌治疗对生育能力的影响、保护生育能力的策略、生育与预后的关系、生育时机等多方面加以综述，为年轻乳腺癌患者的生育抉择提供指导。Abstract: Each woman of childbearing age has the right to enjoy reproduction, including cancer patients. Breast cancer is the most common malignant tumor in women. Many factors led to the significant increase of young patients with fertility problems, and the majority of doctors neglected their reproductive requirements in clinical work. Given the comprehensive treatment, almost every young patient suffers from fertility decline and even loss. Patients who chose to get pregnant also harbor a variety of concerns. This paper reviews the effects of comprehensive treatment on fertility, preservation strategies, pregnancy and prognosis, optimal time for pregnancy, and other aspects and provides guidance for young breast cancer patients in their reproduction choices.
-
Key words:
- breast cancer /
- comprehensive treatment /
- fertility
-
表 1 化疗引起绝经的风险
Table 1. Overview of several chemotherapy regimens
-
[1] 闫庆国. 中国西部地区乳腺癌诊断年龄的抽样分析及中美对比研究[J]. 现代肿瘤医学, 2010, 18(3): 571-573. doi: 10.3969/j.issn.1672-4992.2010.03.056 [2] Christinat A, Pagani O. Fertility after breast cancer[J]. Maturitas, 2012, 73(3): 191-196. doi: 10.1016/j.maturitas.2012.07.013 [3] Maltaris T, Seufert R, Fischl F, et al. The effect of cancer treatment on female fertility and strategies for preserving fertility[J]. Eur J Obstet Gynecol Reprod Biol, 2007, 130(2): 148-155. doi: 10.1016/j.ejogrb.2006.08.006 [4] Wallace WH, Thomson AB, Saran F, et al. Predicting age of ovarianfailure after radiation to a field that includes the ovaries[J]. Int J Radiat Oncol Biol Phys, 2005, 62(2): 738-744. [5] Mazonakis M, Varveris H, Damilakis J, et al. Radiation dose to conceptus resulting from tangential breast irradiation[J]. Int J Radiat Oncol Biol Phys, 2003, 55(2): 386-391. doi: 10.1016/S0360-3016(02)04206-2 [6] Antypas C, Sandilos P, Kouvaris J, et al. Fetal dose evaluation during breast cancer radiotherapy[J]. Int J Radiat Oncol Biol Phys, 1998, 40(4): 995-999. doi: 10.1016/S0360-3016(97)00909-7 [7] Halakivi-Clarke L, Cho E, Onojafe I, et al. Maternal exposure to tamoxifen during pregnancy increases carcinogen-induced mammary tumorigenesis among female rat offspring[J]. Clin Cancer Res, 2000, 6(1): 305-308. [8] Lenhard MS, Bauerfeind I, Untch M. Breast cancer and pregnancy: challenges of chemotherapy[J]. Crit Rev Oncol Hematol, 2008, 67 (3): 196-203. doi: 10.1016/j.critrevonc.2008.02.007 [9] Recchia F, Sica G, De Filippis S, et al. Goserelin as ovarian protection in the adjuvant treatment of premenopausal breast cancer a phase Ⅱ pilot study[J]. Anticancer Drugs, 2002, 13(4): 417-424. doi: 10.1097/00001813-200204000-00011 [10] Wong M, O'Neill S, Walsh G, et al. Goserelin with chemotherapy to preserve ovarian function in pre-menopausal women with early breast cancer: menstruation and pregnancy outcomes[J]. Ann Oncol, 2013, 24(1): 133-138. doi: 10.1093/annonc/mds250 [11] Yang B, Shi W, Yang J, et al. Concurrent treatment with gonadotropin-releasing hormone agonists for chemotherapy-induced ovarian damage in premenopausal women with breast cancer: A meta-analysis of randomized controlled trials[J]. Breast, 2013, 22(2): 150-157. doi: 10.1016/j.breast.2012.12.008 [12] Trounson A, Mohr L. Human pregnancy following cryopreservation, thawing and transfer of an eight-cell embryo[J]. Nature, 1983, 305(5936): 707-709. doi: 10.1038/305707a0 [13] Oktay K. Further evidence on the safety and success of ovarian stimulation with letrozole and tamoxifen in breast cancer patients undergoing in vitro fertilization to cryopreserve their embryos for fertility preservation[J]. J Clin Oncol, 2005, 23(16): 3858-3859. doi: 10.1200/JCO.2005.04.011 [14] Oktay K, Buyuk E, Libertella N, et al. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation[J]. J Clin Oncol, 2005, 23(19): 4347-4353 doi: 10.1200/JCO.2005.05.037 [15] Riggs R, Mayer J, Chi TF, et al. Does storage time influence postthaw survival and pregnancy outcome? An analysis of 11 768 cryopreserved human embryos[J]. Fertil Steril, 2010, 93(1): 109-115. doi: 10.1016/j.fertnstert.2008.09.084 [16] Cobo A, Kuwayama M, Perez S, et al. Comparison of concomitant outcome achieved with fresh and cryopreserved donor oocytes vitrified by the cryotop method[J]. Fertil Steril, 2008, 89(6): 1657-1664. doi: 10.1016/j.fertnstert.2007.05.050 [17] Loren AW, Mangu PB, Beck LN, et al. Fertility Preservation for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update[J]. J Clin Oncol, 2013, 31(19): 2500-2510. doi: 10.1200/JCO.2013.49.2678 [18] Gracia CR, Chang J, Kondapalli L, et al. Ovarian tissue cryopreservation for fertility preservation in cancer patients: successful establishment and feasibility of a multidisciplinary collaboration[J]. J Assisted Reprod Gene, 2012, 29(6): 495-502. doi: 10.1007/s10815-012-9753-7 [19] Donnez J, Silber S, Andersen CY, et al. Children born after autotransplantation of cryopreserved ovarian tissue. A review of 13 live births[J]. Ann Med, 2011, 43(6): 437-450. doi: 10.3109/07853890.2010.546807 [20] Azim HA Jr, Santoro L, Pavlidis N, et al. Safety of pregnancy following breast cancer diagnosis: a meta-analysis of 14 studies[J]. Eur J Cancer, 2011, 47(1): 74-83. doi: 10.1016/j.ejca.2010.09.007 [21] Valachis A, Tsali L, Pesce LL, et al. Safety of pregnancy after primary breast carcinoma in young women a meta-analysis to overcome bias of healthy mother effect studies[J]. Obstet Gynecol Surv, 2011, 65(12): 786-793. [22] Pagani O, Price KN, Gelber RD, et al. Patterns of recurrence of early breast cancer according to estrogen receptor status: a therapeutic target for a quarter of a century[J]. Breast Cancer Res Treat, 2009, 117(2): 319-324. doi: 10.1007/s10549-008-0282-0 [23] Antoniou A, Pharoah PD, Narod S, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies[J]. Am J Hum Genet, 2003, 72(5): 1117-1130. doi: 10.1086/375033 [24] Chen S, Parmigiani G. Meta-analysis of BRCA1 and BRCA2 penetrance[J]. J Clin Oncol, 2007, 25(11): 1329-1333. doi: 10.1200/JCO.2006.09.1066 [25] Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1[J]. Science, 1994, 266(5182): 66-71. doi: 10.1126/science.7545954 [26] Dalberg K, Eriksson J, Holmberg L. Birth outcome in women with previously treated breast cancer-a population-based cohort study from Sweden[J]. PLoS Med, 2006, 3(9): 336. doi: 10.1371/journal.pmed.0030336 [27] Velentgas P, Daling JR, Malone KE, et al. Pregnancy after breast carcinoma: outcomes and influence on mortality[J]. Cancer, 1999, 85(11): 2424-2432. doi: 10.1002/(SICI)1097-0142(19990601)85:11<2424::AID-CNCR17>3.0.CO;2-4 [28] Gelber S, Coates AS, Goldhirsch A, et al. Effect of pregnancy on overall survival after the diagnosis of early-stage breast cancer[J]. J Clin Oncol, 2001, 19(6): 1671-1675. doi: 10.1200/JCO.2001.19.6.1671 [29] Azim HA Jr, Bellettini G, Liptrott SJ, et al. Breastfeeding in breast cancer survivors: pattern, behaviour and effect on breast cancer outcome[J]. Breast, 2010, 19(6): 527-531. doi: 10.1016/j.breast.2010.05.018 [30] Azim HA Jr, Bellettini G, Gelber S, et al. Breast-feeding after breast cancer: if you wish, madam[J]. Breast Cancer Res Treat, 2009, 114 (1): 7-12. doi: 10.1007/s10549-008-9983-7 -
点击查看大图
表(1)
计量
- 文章访问数: 40
- HTML全文浏览量: 25
- PDF下载量: 1
- 被引次数: 0
下载:
